Protective effects of low ‐dose rosuvastatin on isoproterenol‐induced chronic heart failure in rats by regulation of DDAH‐ADMA‐NO pathway
ConclusionsLow‐dose rosuvastatin exerted cardioprotective effects on isoproterenol‐induced heart failure in rats by modulating DDAH‐ADMA‐NO pathway, and it may present the new therapeutic value in ameliorating chronic heart failure.
Source: Cardiovascular Therapeutics - Category: Cardiology Authors: Ru Zhou, Ping Ma, Aiqin Xiong, Yehua Xu, Yang Wang, Qingbin Xu Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
More News: Brain | Cardiology | Cardiovascular | Crestor | Heart | Heart Failure | Neurology | Rosuvastatin | Study